Stratified RCT of ∅3.3 mm vs. ∅4.1 mm hydrophilic titanium-zirconium implants supporting
By Supriya Ebenezer, Sreelakshmi Viswanath, Chitradevi Ramanathan, Alampalli V. Ramesh, Vinay V. Kumar
Originally at onlinelibrary.wiley.com
Summary & scoring by The Bell Brief (Dr. Jennifer Bell) using the Drill-Down Protocol (Drill-Down Score) — not the original publisher.
Why it matters for dental
Implantologists and restorative dentists treating posterior mandibular cases in hyperglycaemic patients can now use RCT evidence to decide between narrow-diameter (∅3.3 mm) and standard (∅4.1 mm) hydrophilic Ti-Zr implants, directly affecting prosthetic planning and risk management.
Key points
- Stratified RCT published in Clinical Oral Implants Research, EarlyView, compares ∅3.3 mm vs ∅4.1 mm hydrophilic titanium-zirconium implants supporting posterior mandibular fixed prostheses in hyperglycaemic subjects.
- Study population limited to hyperglycaemic patients, providing targeted data for clinicians managing implant cases in this medically complex group.
- Findings inform implant diameter selection for posterior mandible, influencing biomechanical considerations and prosthetic design in hyperglycaemic cohorts.
- Academic and specialist clinicians (prosthodontists, periodontists, oral surgeons) should integrate these results into treatment planning for medically compromised patients.
Who should care
Read the original on Clinical Oral Implants Research
Full reporting and any paywall content live on onlinelibrary.wiley.com. We summarize and score; we do not republish.
Related
- ·Research
From mouth to brain: linking periodontal and peri-implant dysbiosis to systemic
- ·Research
Herpes zoster ophthalmicus following endodontic treatment: a case report
- ·Research
Formulation-dependent hydrothermal degradation of ultratranslucent 5y-tzp zirconia
- ·Regulatory
California Expands Access to Fluoride Varnish